• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

联合因子 V 和因子 VIII 缺乏症两个致病基因产物协同作用的结构基础。

Structural basis for the cooperative interplay between the two causative gene products of combined factor V and factor VIII deficiency.

机构信息

Department of Structural Biology and Biomolecular Engineering, Graduate School of Pharmaceutical Sciences, Nagoya City University, 3-1 Tanabe-dori, Mizuho-ku, Nagoya 467-8603, Japan.

出版信息

Proc Natl Acad Sci U S A. 2010 Mar 2;107(9):4034-9. doi: 10.1073/pnas.0908526107. Epub 2010 Feb 8.

DOI:10.1073/pnas.0908526107
PMID:20142513
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2840101/
Abstract

Combined deficiency of coagulation factors V and VIII (F5F8D), an autosomal recessive disorder characterized by coordinate reduction in the plasma levels of factor V (FV) and factor VIII (FVIII), is genetically linked to mutations in the transmembrane lectin ERGIC-53 and the soluble calcium-binding protein MCFD2. Growing evidence indicates that these two proteins form a complex recycling between the endoplasmic reticulum (ER) and the ER-Golgi intermediate compartment and thereby function as a cargo receptor in the early secretory pathway of FV and FVIII. For better understanding of the mechanisms underlying the functional coordination of ERGIC-53 and MCFD2, we herein characterize their interaction by x-ray crystallographic analysis in conjunction with NMR and ultracentrifugation analyses. Inspection of the combined data reveals that ERGIC-53-CRD binds MCFD2 through its molecular surface remote from the sugar-binding site, giving rise to a 11 complex in solution. The interaction is independent of sugar-binding of ERGIC-53 and involves most of the missense mutation sites of MCFD2 so far reported in F5F8D. Comparison with the previously reported uncomplexed structure of each protein indicates that MCFD2 but not ERGIC-53-CRD undergoes significant conformational alterations upon complex formation. Our findings provide a structural basis for the cooperative interplay between ERGIC-53 and MCFD2 in capturing FV and FVIII.

摘要

凝血因子 V 和 VIII 联合缺乏症(F5F8D)是一种常染色体隐性疾病,其特征是血浆因子 V(FV)和因子 VIII(FVIII)水平协同降低,该疾病与跨膜凝集素 ERGIC-53 和可溶性钙结合蛋白 MCFD2 中的突变遗传相关。越来越多的证据表明,这两种蛋白质在 ER 和 ER-Golgi 中间隔室之间形成一个循环复合物,从而作为 FV 和 FVIII 的早期分泌途径中的货物受体发挥作用。为了更好地理解 ERGIC-53 和 MCFD2 功能协调的机制,我们通过 X 射线晶体学分析结合 NMR 和超速离心分析来表征它们的相互作用。综合数据的检查表明,ERGIC-53-CRD 通过远离糖结合位点的分子表面结合 MCFD2,导致复合物在溶液中形成。该相互作用不依赖于 ERGIC-53 的糖结合,并且涉及迄今为止在 F5F8D 中报道的 MCFD2 的大多数错义突变位点。与先前报道的每种蛋白质的未复合结构进行比较表明,MCFD2 而不是 ERGIC-53-CRD 在形成复合物时会发生显著的构象改变。我们的发现为 ERGIC-53 和 MCFD2 在捕获 FV 和 FVIII 中的协同作用提供了结构基础。

相似文献

1
Structural basis for the cooperative interplay between the two causative gene products of combined factor V and factor VIII deficiency.联合因子 V 和因子 VIII 缺乏症两个致病基因产物协同作用的结构基础。
Proc Natl Acad Sci U S A. 2010 Mar 2;107(9):4034-9. doi: 10.1073/pnas.0908526107. Epub 2010 Feb 8.
2
Deletion of 3 residues from the C-terminus of MCFD2 affects binding to ERGIC-53 and causes combined factor V and factor VIII deficiency.从MCFD2的C末端缺失3个残基会影响其与ERGIC-53的结合,并导致凝血因子V和凝血因子VIII联合缺乏。
Blood. 2008 Feb 1;111(3):1299-301. doi: 10.1182/blood-2007-09-112854. Epub 2007 Oct 30.
3
Structural characterization of carbohydrate binding by LMAN1 protein provides new insight into the endoplasmic reticulum export of factors V (FV) and VIII (FVIII).通过 LMAN1 蛋白对碳水化合物结合的结构特征,为因子 V (FV) 和 VIII (FVIII) 的内质网输出提供了新的见解。
J Biol Chem. 2013 Jul 12;288(28):20499-509. doi: 10.1074/jbc.M113.461434. Epub 2013 May 24.
4
Combined deficiency of coagulation factors V and VIII: an update.凝血因子 V 和 VIII 联合缺乏症:更新。
Semin Thromb Hemost. 2013 Sep;39(6):613-20. doi: 10.1055/s-0033-1349223. Epub 2013 Jul 12.
5
Recent developments in the understanding of the combined deficiency of FV and FVIII.对因子V和因子VIII联合缺乏症认识的最新进展。
Br J Haematol. 2009 Apr;145(1):15-23. doi: 10.1111/j.1365-2141.2008.07559.x. Epub 2009 Jan 16.
6
Combined deficiency of factor V and factor VIII is due to mutations in either LMAN1 or MCFD2.因子V和因子VIII联合缺乏是由LMAN1或MCFD2中的突变引起的。
Blood. 2006 Mar 1;107(5):1903-7. doi: 10.1182/blood-2005-09-3620. Epub 2005 Nov 22.
7
Mutations in the MCFD2 gene are predominant among patients with hereditary combined FV and FVIII deficiency (F5F8D) in India.在印度,遗传性联合因子V和因子VIII缺乏症(F5F8D)患者中,MCFD2基因突变最为常见。
Haemophilia. 2007 Jul;13(4):413-9. doi: 10.1111/j.1365-2516.2007.01477.x.
8
Crystal structure of the LMAN1-CRD/MCFD2 transport receptor complex provides insight into combined deficiency of factor V and factor VIII.LMAN1-CRD/MCFD2 转运受体复合物的晶体结构为研究凝血因子 V 和凝血因子 VIII 联合缺乏症提供了线索。
FEBS Lett. 2010 Mar 5;584(5):878-82. doi: 10.1016/j.febslet.2010.02.009. Epub 2010 Feb 9.
9
Two new mutations at ERGIC-53 gene in a Turkish family.一个土耳其家族中 ERGIC-53 基因的两个新突变。
Clin Appl Thromb Hemost. 2011 Jun;17(3):248-50. doi: 10.1177/1076029609355153. Epub 2010 May 11.
10
Genotype-phenotype correlation in combined deficiency of factor V and factor VIII.凝血因子V和凝血因子VIII联合缺乏的基因型-表型相关性
Blood. 2008 Jun 15;111(12):5592-600. doi: 10.1182/blood-2007-10-113951. Epub 2008 Apr 7.

引用本文的文献

1
Molecular tag for promoting -glycan maturation in the cargo receptor-mediated secretion pathway.用于在货物受体介导的分泌途径中促进聚糖成熟的分子标签。
iScience. 2024 Nov 22;27(12):111457. doi: 10.1016/j.isci.2024.111457. eCollection 2024 Dec 20.
2
Clinical, Laboratory, Molecular, and Reproductive Aspects of Combined Deficiency of Factors V and VIII.因子V和因子VIII联合缺乏的临床、实验室、分子及生殖方面
Semin Thromb Hemost. 2025 Mar;51(2):116-127. doi: 10.1055/s-0044-1789019. Epub 2024 Aug 29.
3
Structure of full-length ERGIC-53 in complex with MCFD2 for cargo transport.全长 ERGIC-53 与 MCFD2 复合物的结构用于货物运输。
Nat Commun. 2024 Mar 16;15(1):2404. doi: 10.1038/s41467-024-46747-1.
4
Mammalian cargo receptors for endoplasmic reticulum-to-Golgi transport: mechanisms and interactions.内质网到高尔基体运输的哺乳动物货物受体:机制和相互作用。
Biochem Soc Trans. 2023 Jun 28;51(3):971-981. doi: 10.1042/BST20220713.
5
LMAN1-MCFD2 complex is a cargo receptor for the ER-Golgi transport of α1-antitrypsin.LMAN1-MCFD2 复合物是 α1-抗胰蛋白酶在 ER-Golgi 运输中的货物受体。
Biochem J. 2022 Apr 14;479(7):839-855. doi: 10.1042/BCJ20220055.
6
Glycans in autophagy, endocytosis and lysosomal functions.糖链在自噬、内吞作用和溶酶体功能中的作用。
Glycoconj J. 2021 Oct;38(5):625-647. doi: 10.1007/s10719-021-10007-x. Epub 2021 Aug 14.
7
Crystallographic snapshots of the EF-hand protein MCFD2 complexed with the intracellular lectin ERGIC-53 involved in glycoprotein transport.晶体学快照显示 EF 手蛋白 MCFD2 与参与糖蛋白运输的细胞内凝集素 ERGIC-53 形成复合物。
Acta Crystallogr F Struct Biol Commun. 2020 May 1;76(Pt 5):216-221. doi: 10.1107/S2053230X20005452. Epub 2020 Apr 29.
8
Improved secretion of glycoproteins using an N-glycan-restricted passport sequence tag recognized by cargo receptor.利用被货物受体识别的 N-糖链受限护照序列标签提高糖蛋白的分泌
Nat Commun. 2020 Mar 13;11(1):1368. doi: 10.1038/s41467-020-15192-1.
9
Structural basis for two-step glucose trimming by glucosidase II involved in ER glycoprotein quality control.参与内质网糖蛋白质量控制的葡糖苷酶II两步葡萄糖修剪的结构基础。
Sci Rep. 2016 Feb 5;6:20575. doi: 10.1038/srep20575.
10
Analysis of COPII Vesicles Indicates a Role for the Emp47-Ssp120 Complex in Transport of Cell Surface Glycoproteins.对COPII囊泡的分析表明Emp47-Ssp120复合物在细胞表面糖蛋白运输中发挥作用。
Traffic. 2016 Mar;17(3):191-210. doi: 10.1111/tra.12356. Epub 2016 Jan 10.

本文引用的文献

1
The implementation of SOMO (SOlution MOdeller) in the UltraScan analytical ultracentrifugation data analysis suite: enhanced capabilities allow the reliable hydrodynamic modeling of virtually any kind of biomacromolecule.在 UltraScan 分析超速离心数据分析套件中实现 SOMO(Solution MOdeller):增强的功能可实现几乎任何类型的生物大分子的可靠流体力学建模。
Eur Biophys J. 2010 Feb;39(3):423-35. doi: 10.1007/s00249-009-0418-0. Epub 2009 Feb 21.
2
Recent developments in the understanding of the combined deficiency of FV and FVIII.对因子V和因子VIII联合缺乏症认识的最新进展。
Br J Haematol. 2009 Apr;145(1):15-23. doi: 10.1111/j.1365-2141.2008.07559.x. Epub 2009 Jan 16.
3
New insights into multiple coagulation factor deficiency from the solution structure of human MCFD2.基于人MCFD2溶液结构对多种凝血因子缺乏症的新见解。
J Mol Biol. 2008 Sep 12;381(4):941-55. doi: 10.1016/j.jmb.2008.06.042. Epub 2008 Jun 20.
4
Genotype-phenotype correlation in combined deficiency of factor V and factor VIII.凝血因子V和凝血因子VIII联合缺乏的基因型-表型相关性
Blood. 2008 Jun 15;111(12):5592-600. doi: 10.1182/blood-2007-10-113951. Epub 2008 Apr 7.
5
The sugar-binding ability of ERGIC-53 is enhanced by its interaction with MCFD2.ERGIC-53与MCFD2的相互作用增强了其糖结合能力。
Blood. 2008 Feb 15;111(4):1972-9. doi: 10.1182/blood-2007-06-097022. Epub 2007 Dec 3.
6
Molecular basis of sugar recognition by the human L-type lectins ERGIC-53, VIPL, and VIP36.人L型凝集素ERGIC-53、VIPL和VIP36识别糖的分子基础。
J Biol Chem. 2008 Jan 25;283(4):1857-61. doi: 10.1074/jbc.M709384200. Epub 2007 Nov 19.
7
Deletion of 3 residues from the C-terminus of MCFD2 affects binding to ERGIC-53 and causes combined factor V and factor VIII deficiency.从MCFD2的C末端缺失3个残基会影响其与ERGIC-53的结合,并导致凝血因子V和凝血因子VIII联合缺乏。
Blood. 2008 Feb 1;111(3):1299-301. doi: 10.1182/blood-2007-09-112854. Epub 2007 Oct 30.
8
Structural basis for recognition of high mannose type glycoproteins by mammalian transport lectin VIP36.哺乳动物转运凝集素VIP36识别高甘露糖型糖蛋白的结构基础。
J Biol Chem. 2007 Sep 21;282(38):28246-55. doi: 10.1074/jbc.M703064200. Epub 2007 Jul 25.
9
Structures and metal-ion-binding properties of the Ca2+-binding helix-loop-helix EF-hand motifs.钙离子结合螺旋-环-螺旋EF手基序的结构与金属离子结合特性
Biochem J. 2007 Jul 15;405(2):199-221. doi: 10.1042/BJ20070255.
10
Structural views of glycoprotein-fate determination in cells.细胞中糖蛋白命运决定的结构观点。
Glycobiology. 2007 Oct;17(10):1031-44. doi: 10.1093/glycob/cwm046. Epub 2007 Apr 20.